Application of the direct beta counter Matrix 96 for cytotoxic assays: Simultaneous processing and reading of 96 wells using a51Cr-retention assay Gilda G. HillmanNorbert RoesslerGabriel P. Haas Original articles Pages: 351 - 356
Eradication of metastatic tumour cells from lymph nodes by local administration of anti-CD3 antibody Yoshitane DohiShoji SunadaHikaru Matsuda Original articles Pages: 357 - 363
Antitumor response independent of functional B or T lymphocytes induced by the local and sustained release of interleukin-2 by the tumor cells Thomas AloscoB. Anne CroyRichard Bankert Original articles Pages: 364 - 372
A mouse/human chimeric anti-(ganglioside GD3) antibody with enhanced antitumor activities Kenya ShitaraYoshihisa KuwanaNobuo Hanai Original articles Pages: 373 - 380
The immunogenic properties of drug-resistant murine tumor cells do not correlate with expression of the MDR phenotype Jerald J. KillionRobert RadinskyIsaiah J. Fidler Original articles Pages: 381 - 386
IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cells Myron S. CzuczmanPilar Garin-ChesaDavid A. Scheinberg Original articles Pages: 387 - 396
Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalency Uppugunduri SrinivasElda TagliabueMaria Ines Colnaghi Original articles Pages: 397 - 402
The development and purification of a bispecific antibody for lymphokine-activated killer cell targeting against the rat colon carcinoma CC531 Peter J. K. KuppenAlexander M. M. EggermontGert Jan Fleuren Original articles Pages: 403 - 408
Factors, including transforming growth factor β, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells Pier Adelchi RuffiniLicia RivoltiniGiorgio Parmiani Original articles Pages: 409 - 416
